• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

析因生存实验分析

Analysis of factorial survival experiments.

作者信息

Slud E V

机构信息

Mathematics Department, University of Maryland, College Park 20742.

出版信息

Biometrics. 1994 Mar;50(1):25-38.

PMID:8086609
Abstract

Several new methodological issues that arise within two-way factorial designs for survival experiments are discussed within the framework of asymptotic theory for the proportional hazards model with two binary treatment covariates. These issues include: the proper formulation of null hypotheses and alternatives, the choice among log-rank and adjusted or stratified log-rank statistics, the asymptotic correlation between test statistics for the separate main effects, the asymptotic power (under the various possible methods of analysis) of tests to detect main effects and interactions, the comparison of power to detect main effects within a 2 x 2 factorial design with power in a three-group trial where no patients are randomized simultaneously to both treatments, and the problems of analysis arising when accrual or exposure to one of the treatments is terminated early for ethical reasons.

摘要

在具有两个二元治疗协变量的比例风险模型的渐近理论框架内,讨论了双向析因生存实验中出现的几个新的方法学问题。这些问题包括:原假设和备择假设的恰当表述、对数秩检验与调整或分层对数秩统计量之间的选择、单独主效应检验统计量之间的渐近相关性、检测主效应和交互作用的检验(在各种可能的分析方法下)的渐近功效、在2×2析因设计中检测主效应的功效与在三组试验(其中没有患者同时被随机分配到两种治疗)中的功效比较,以及由于伦理原因提前终止一种治疗的入组或暴露时出现的分析问题。

相似文献

1
Analysis of factorial survival experiments.析因生存实验分析
Biometrics. 1994 Mar;50(1):25-38.
2
Bayesian design and analysis of two x two factorial clinical trials.两因素二水平析因临床试验的贝叶斯设计与分析
Biometrics. 1997 Jun;53(2):456-64.
3
Dynamic comparison of Kaplan-Meier proportions: monitoring a randomized clinical trial with a long-term binary endpoint.Kaplan-Meier 比例的动态比较:监测具有长期二元终点的随机临床试验
Biometrics. 2008 Mar;64(1):189-97. doi: 10.1111/j.1541-0420.2007.00874.x. Epub 2007 Aug 3.
4
The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.用于协变量调整的非参数对数秩检验和威尔科克森检验的I型错误率及检验效能——一项模拟研究
Stat Med. 2008 Dec 10;27(28):5850-60. doi: 10.1002/sim.3406.
5
Sample size determination for comparing several survival curves with unequal allocations.用于比较几个不等分配的生存曲线的样本量确定。
Stat Med. 2004 Jun 15;23(11):1793-815. doi: 10.1002/sim.1771.
6
Some permutation tests for survival data.一些针对生存数据的排列检验。
Biometrics. 1996 Mar;52(1):87-97.
7
Combining stratified and unstratified log-rank tests in paired survival data.配对生存数据中分层和非分层对数秩检验的联合应用。
Stat Med. 2010 Jul 20;29(16):1735-45. doi: 10.1002/sim.3921.
8
A note on P-values under group sequential testing and nonproportional hazards.关于成组序贯检验和非比例风险下的P值的注释
Biometrics. 2005 Jun;61(2):546-51. doi: 10.1111/j.1541-0420.2005.040342.x.
9
Optimal conditional error functions for the control of conditional power.用于控制条件功效的最优条件误差函数。
Biometrics. 2004 Sep;60(3):715-23. doi: 10.1111/j.0006-341X.2004.00221.x.
10
Extension of the rank sum test for clustered data: two-group comparisons with group membership defined at the subunit level.聚类数据秩和检验的扩展:在亚单位水平定义组成员的两组比较。
Biometrics. 2006 Dec;62(4):1251-9. doi: 10.1111/j.1541-0420.2006.00582.x.

引用本文的文献

1
Guidance for protocol content and reporting of factorial randomised trials: explanation and elaboration of the CONSORT 2010 and SPIRIT 2013 extensions.析因随机试验的方案内容与报告指南:CONSORT 2010和SPIRIT 2013扩展版的解释与阐述
BMJ. 2025 Feb 4;388:e080785. doi: 10.1136/bmj-2024-080785.
2
Consensus Statement for Protocols of Factorial Randomized Trials: Extension of the SPIRIT 2013 Statement.《析因随机临床试验方案的共识声明:SPIRIT 2013 声明的扩展》。
JAMA Netw Open. 2023 Dec 1;6(12):e2346121. doi: 10.1001/jamanetworkopen.2023.46121.
3
Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement.
报告析因随机试验:CONSORT 2010 声明的扩展。
JAMA. 2023 Dec 5;330(21):2106-2114. doi: 10.1001/jama.2023.19793.
4
Simultaneous inference on treatment effects in survival studies with factorial designs.析因设计生存研究中治疗效果的同时推断。
Biometrics. 2016 Dec;72(4):1078-1085. doi: 10.1111/biom.12507. Epub 2016 Mar 17.
5
Sample size calculation for rank tests comparing K survival distributions.比较K个生存分布的秩检验的样本量计算。
Lifetime Data Anal. 2002 Dec;8(4):361-73. doi: 10.1023/a:1020518905233.
6
Urn sampling and the proportional hazard model.瓮抽样与比例风险模型。
Lifetime Data Anal. 1998;4(4):309-27. doi: 10.1023/a:1009626002246.